Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo

por Vannas, Christoffer, Andersson, Lisa, Dolatabadi, Soheila, Ranji, Parmida, Lindén, Malin, Jonasson, Emma, Ståhlberg, Anders, Fagman, Henrik, Åman, Pierre
Publicado 2022

FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma

por Lindén, Malin, Vannas, Christoffer, Österlund, Tobias, Andersson, Lisa, Osman, Ayman, Escobar, Mandy, Fagman, Henrik, Ståhlberg, Anders, Åman, Pierre
Publicado 2022

Cell Cycle and Cell Size Dependent Gene Expression Reveals Distinct Subpopulations at Single-Cell Level

por Dolatabadi, Soheila, Candia, Julián, Akrap, Nina, Vannas, Christoffer, Tesan Tomic, Tajana, Losert, Wolfgang, Landberg, Göran, Åman, Pierre, Ståhlberg, Anders
Publicado 2017

FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex

por Lindén, Malin, Thomsen, Christer, Grundevik, Pernilla, Jonasson, Emma, Andersson, Daniel, Runnberg, Rikard, Dolatabadi, Soheila, Vannas, Christoffer, Luna Santamarίa, Manuel, Fagman, Henrik, Ståhlberg, Anders, Åman, Pierre
Publicado 2019

HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo

por Safavi, Setareh, Järnum, Sofia, Vannas, Christoffer, Udhane, Sameer, Jonasson, Emma, Tomic, Tajana Tesan, Grundevik, Pernilla, Fagman, Henrik, Hansson, Magnus, Kalender, Zeynep, Jauhiainen, Alexandra, Dolatabadi, Soheila, Stratford, Eva Wessel, Myklebost, Ola, Eriksson, Mikael, Stenman, Göran, Stock, Regine Schneider, Ståhlberg, Anders, Åman, Pierre
Publicado 2015